Decheng Capital backs early‑stage life‑science ventures with breakthrough technologies and growth‑stage healthcare companies that have clear market traction. The firm leverages deep scientific expertise and strategic partnerships to accelerate product development and scale. Its global perspective and sizable capital enable it to support companies from discovery through commercialization.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
Global
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
64.4%People's Republic of China
8.9%United Kingdom
2.2%Hong Kong
2.2%Singapore
2.2%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Seed → Series C+
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund V
$700.0M